Anal Carcinoma Therapy: Can We Improve on 5-Fluorouracil/Mitomycin/Radiotherapy?

By Jiang Yixing   Mackley Heath   Cheng Hua   Ajani Jaffer A.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 8, Iss. 1, 2010-01 ,pp. : 135-144

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282

By Jhawer Minaxi   Mani Sridhar   Lefkopoulou Myrto   Hahn Richard   Harris Jules   Catalano Paul   Haller Daniel  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 447-454

Springer Publishing Company

Access to resources Recommend Favorite

Fluorouracil + folinic acid + cisplatin active in gastric cancer

By  

Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Cisplatin, fluorouracil, docetaxel in head and neck cancer

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Irinotecan plus fluorouracil and folinic acid should be the comparator regimen in clinical trials involving patients with metastatic colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite